Second primary cancers after liver, gallbladder and bile duct cancers, and these cancers as second primary cancers

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Search: id:"swepub:oai:lup.lub.lu.se:02801fbf-9924-4d6f-a264-a34ff59febe4" > Second primary canc...

1 of 1
Previous record
Next record
To hitlist

Details
MARC

Zheng, GuoqiaoLund University,Lunds universitet,Allmänmedicin och klinisk epidemiologi,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Family Medicine and Clinical Epidemiology,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,German Cancer Research Centre (author)

Second primary cancers after liver, gallbladder and bile duct cancers, and these cancers as second primary cancers

Article/chapterEnglish2021

Publisher, publication year, extent ...

2021
9 s.

Numbers

LIBRIS-ID:oai:lup.lub.lu.se:02801fbf-9924-4d6f-a264-a34ff59febe4
https://lup.lub.lu.se/record/02801fbf-9924-4d6f-a264-a34ff59febe4URI
https://doi.org/10.2147/CLEP.S318737DOI

Supplementary language notes

Language:English
Summary in:English

Part of subdatabase

SwePubSwePub

Classification

Subject category:art swepub-publicationtype
Subject category:ref swepub-contenttype

Notes

Background: Second primary cancers (SPCs) are important clinically as they may negatively influence patient survival and they may tell about therapeutic side effects and general causes of cancer. Population-based literature concerning SPCs after hepatobiliary cancers is limited and here we assess risks of SPCs after hepatocellular cancer (HCC), and cancers of the gallbladder, bile ducts and ampulla of Vater. In reverse order, we consider the risk of hepatobiliary cancers as SPCs after any cancer. Methods: We used standardized incidence ratios (SIRs) to estimate bidirectional relative risks of subsequent cancers associated with hepatobiliary cancers. Cancer diagnoses were obtained from the Swedish Cancer Registry from years 1990 through 2015. Results: We identified 9997 primary HCCs, 1365 gallbladder cancers and 4721 bile duct cancers. After HCC, risks of four SPCs were increased: gallbladder (SIR = 4.38; 95% confidence interval 1.87–8.67), thyroid (4.13; 1.30–9.70), kidney (2.92; 1.66–4.47) and squamous cell skin (1.55; 1.02–2.26) cancers. In reverse order, HCC as SPC, in addition to the above cancers, associations included upper aerodigestive tract, esophageal, small intestinal and bladder cancers and non-Hodgkin lymphoma. For gallbladder and bile duct cancers, associations were found with small intestinal and pancreatic cancers. Conclusion: The results suggested that HCC is associated with two types of SPC, one related to shared environmental risk factors, such as alcohol, exemplified by upper aero-digestive tract and esophageal cancer, and the other related to immune dysfunction, exemplified by squamous cell skin cancer. SPCs associated with gallbladder and bile duct cancers suggest predisposition to mutations in the mismatch repair gene MLH1.

Subject headings and genre

MEDICIN OCH HÄLSOVETENSKAP Klinisk medicin Cancer och onkologi hsv//swe
MEDICAL AND HEALTH SCIENCES Clinical Medicine Cancer and Oncology hsv//eng
Cancer etiology
Cancer incidence
Hepatobiliary cancer
Relative risk
Second primary cancer

Added entries (persons, corporate bodies, meetings, titles ...)

Sundquist, KristinaLund University,Lunds universitet,Allmänmedicin och klinisk epidemiologi,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Family Medicine and Clinical Epidemiology,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Icahn School of Medicine at Mount Sinai,Shimane University(Swepub:lu)med-ksq (author)
Sundquist, JanLund University,Lunds universitet,Allmänmedicin och klinisk epidemiologi,Forskargrupper vid Lunds universitet,LUCC: Lunds universitets cancercentrum,Övriga starka forskningsmiljöer,Family Medicine and Clinical Epidemiology,Lund University Research Groups,LUCC: Lund University Cancer Centre,Other Strong Research Environments,Shimane University,Icahn School of Medicine at Mount Sinai(Swepub:lu)med-jsu (author)
Chen, TianhuiUniversity of the Chinese Academy of Sciences(Swepub:lu)med-tce (author)
Försti, AstaIcahn School of Medicine at Mount Sinai,German Cancer Research Centre,Hopp Children’s Cancer Center Heidelberg (KiTZ)(Swepub:lu)med-asf (author)
Hemminki, AkseliUniversity of Helsinki,Helsinki University Central Hospital (author)
Liska, VaclavUniversity Hospital in Pilsen,Charles University in Prague (author)
Hemminki, KariGerman Cancer Research Centre,Icahn School of Medicine at Mount Sinai,Charles University in Prague(Swepub:lu)med-khk (author)
Allmänmedicin och klinisk epidemiologiForskargrupper vid Lunds universitet (creator_code:org_t)

Related titles

In:Clinical Epidemiology13, s. 683-6911179-1349

Internet link

Find in a library

Clinical Epidemiology (Search for host publication in LIBRIS)

To the university's database

1 of 1
Previous record
Next record
To hitlist

Find more in SwePub

By the author/editor: Zheng, Guoqiao; Sundquist, Krist ...; Sundquist, Jan; Chen, Tianhui; Försti, Asta; Hemminki, Akseli; show more...; Liska, Vaclav; Hemminki, Kari; show less...

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Cancer and Oncol ...

Articles in the publication: Clinical Epidemi ...

By the university: Lund University

Search outside SwePub

Extend your search to:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se